Summary
UnitedHealth Group Inc. (UNH) filed an 8-K on July 23, 2015, primarily to disclose information related to the completion of its subsidiary Optum's acquisition of Catamaran Corporation. This filing confirms the successful integration of Catamaran, a pharmacy benefits manager, into Optum's operations. The transaction's completion is a significant step for UnitedHealth Group, enhancing its capabilities and market position within the health services sector, particularly in pharmacy benefits management. Furthermore, the press release attached as an exhibit details the financial aspects of the Catamaran acquisition, including the redemption of Catamaran's outstanding public notes and the payoff of its existing credit facility. This information is crucial for investors to understand the financing and closure of this major strategic move, signifying the immediate financial execution following the deal's finalization and the successful de-leveraging of the acquired entity.
Key Highlights
- 1Confirmation of the completion of Optum's (a subsidiary of UNH) combination with Catamaran Corporation.
- 2Announcement of the scheduled redemption of Catamaran's outstanding public notes.
- 3Disclosure of the satisfaction and discharge of the indenture related to Catamaran's public notes.
- 4Information regarding the payoff and termination of Catamaran's existing credit facility.
- 5The press release detailing these events is furnished as Exhibit 99.1.
- 6The filing serves as a Regulation FD disclosure, ensuring transparency around material events.
- 7The Arrangement Agreement for the acquisition was previously filed on March 30, 2015.